Neurobiologist Andrew Gallimore and a team of clinical experts are launching Eleusis, a specialized research facility on the Caribbean island of Bequia, to establish sustained two-way communication with non-human entities encountered during DMT-induced states. Starting March 18, the center will utilize “DMTx” technology—a continuous intravenous drip—to extend the typically brief psychedelic experience, allowing for a systematic “SETI for the mind” approach to mapping what participants describe as hyper-intelligent, technological realms.
Precision Psychedelics: The Evolution of the DMTx Protocol
The standard dimethyltryptamine (DMT) experience is often described as a “guillotine” drop—a violent, rapid propulsion into an alien landscape that ends as quickly as it begins. To bypass these temporal limitations, Eleusis employs a sophisticated IV-based titration system. This method allows medical supervisors to regulate the drug flow, maintaining the user in a stable psychedelic state for extended periods. Unlike Ayahuasca, which involves a grueling multi-hour physical ordeal often accompanied by nausea, the DMTx protocol offers a “digestible” alternative where the intensity can be dialed back or terminated instantly if the subject experiences distress.
Bridging the Gap Between Science and Spiritual Pilgrimage
Named after the ancient Greek site of spiritual initiation, Eleusis operates in a legal jurisdiction where licensed providers can administer DMT. The facility’s research wing is managed by Noonautics, Gallimore’s non-profit dedicated to exploring the boundaries of human consciousness. Simultaneously, the therapeutic operations are led by Charles Patti and Christina Thomas, owners of a Florida-based ketamine clinic. While the primary focus remains on entity communication, the team acknowledges the profound therapeutic potential of DMT for treating major depressive disorder and alcohol use disorder. A four-day residency package, priced at $9,500, includes two DMTx sessions, medical screening, and holistic integration practices like breathwork.
The Great Debate: Neural Projection vs. Independent Reality
The core of Gallimore’s research targets a phenomenon reported by users worldwide: encounters with “self-transforming elf machines” or godlike intelligences that appear to possess independent agency. In his work, Death by Astonishment, Gallimore argues that DMT may unlock a sensory realm ordinarily inaccessible to the human brain, populated by entities that are not mere hallucinations. He contends that these beings are too radically distinct from human experience to be dismissed as simple unconscious archetypes.
However, mainstream neuroscience offers a more skeptical interpretation. Robin Carhart-Harris, a prominent neurology researcher at UC San Francisco, suggests these encounters are a “higher-order version of seeing faces in clouds.” He argues that humans are evolutionarily primed to detect sentient beings, and the high-entropy state of a DMT trip causes the brain’s social processing hardware to misfire, creating the illusion of an external intelligence.
A Multidisciplinary Expedition Into Inner Space
To resolve the question of entity independence, Gallimore proposes a rigorous, multidisciplinary mapping of the DMT space. He envisions sending linguists, mathematicians, and cartographers into the realm to analyze its structural features, much like scientists exploring a newly discovered rainforest. Some researchers have suggested testing the entities’ intelligence through complex mathematical tasks, such as factoring large prime numbers—capabilities that exceed the human subject’s conscious power.
Whether these beings exist independently or as complex neural reflections, the clinical impact remains undeniable. For many participants, including co-founder Charles Patti, these encounters provide the psychological breakthrough necessary to overcome long-term addiction. The subjective reality of the experience, regardless of its ontological status, serves as a powerful catalyst for permanent behavioral change and emotional healing.
